Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
First Appeared on 12/8/2009
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|HPV4: HPV (GARDASIL) / MERCK & CO. INC.||- / -||UN / UN|
Administered by: Unknown Purchased by: Unknown
Symptoms: Menorrhagia, Thrombosis, Activities of daily living impaired
Life Threatening? No
Permanent Disability? Yes
ER or Doctor Visit? No
Other Medications: Unknown
Preexisting Conditions: Unknown
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES0812USA02074
Write-up:This case was initially reported to an agency by the health authority and it concerns a 12 year old female patient. The patient had 28 day menstrual cycles with five days bleeding. The patient received GARDASIL. Batch number not reported, on 16-OCT-2008. On 28-OCT-2008, 12 days post vaccination, the patient experienced heavy bleeding with clots which was described as very abnormal and the patient was unable to attend school. At the time of the reporting the patient had not yet recovered. The reporter considered the event to be disabling and medically significant. Other business partner numbers include E200811402. No further information is available.
Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166